Kolkata, West Bengal -- (SBWIRE) -- 09/19/2013 -- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on Prima Biomed Ltd.(NASDAQ:PBMD), Costar Technologies Inc(OTCMKTS:CSTI), Viropharma Inc(NASDAQ:VPHM).
Prima Biomed Ltd.(NASDAQ:PBMD) plummets after releasing a topline analysis of the CVac epithelial ovarian cancer Phase 2 study.PFS data prove "inconclusive" as "the estimate of median progression-free survival for all randomized patients resulted in no observed difference between the CVac and control groups."When estimated separately for patients in first and second remission, median PFS favored the control arm for first remission and CVac for second remission (no statistical significance for either result).It's too early to draw OS conclusions.
The company says the recent MAGE-A3 melanoma trial results might "indicate that PFS (and similar endpoints like disease-free survival) may not be useful markers of clinical benefit for cancer immunotherapeutics."
Should Investors Buy PBMD After Yesterday’s Jump? Find Out Here
Costar Technologies Inc(OTCMKTS:CSTI) spike after SA Pro's Money Treez makes the case (under embargo until 9:30 ET tomorrow) that the video monitoring/security company is delivering strong profitability and above-average return on capital while trading below book value.
Based on comparables, the analysis points to a potential upside of up to 290% with a favorable risk/reward ratio.
How Should Investors Trade CSTI After The Recent Volatility? Get Free Trend Analysis Here
Viropharma Inc(NASDAQ:VPHM) "began working with Goldman Sachs Group Inc. on a possible auction after fielding an unsolicited approach," Bloomberg said last week.Does that make it bad for those anticipating a big takeout premium that Goldman analyst Terence Flynn is out today raising his price target to just $30, more than $10 lower than the stock's current price?It may be food for thought if you're the type who likes to try and connect the dots. Officially, the new target price is derived from a change to the discount rate in Goldman's DCF model.
Is VPHM A Good Buy After The Recent Price Movement? Find Out Here
Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.
The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)